How do you pay?

How to pay the least

Ask for the cash price

Prezcobix Ped

We didn’t find one.

  1. Ask your pharmacy for Prezcobix Ped’s cash price, and one or two other pharmacies too.
  2. Prezcobix Ped’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand namePrezcobix Ped
Authorized genericdarunavir ethanolate and cobicistat
Regular genericdarunavir ethanolate and cobicistat
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Prezcobix Ped?
The original
–
–

Brand nameThe maker’s card

J&J withMe Savings Program

Savings card from Johnson & Johnson (Janssen)

No insuranceNeeds insuranceNo cash price listed.
Insurance $0 a fill

Sign up on jnjwithme.com 

Or text SAVINGS to 89633, or call 1-833-742-0791.

In the maker’s words

“Your eligible patients will pay $0 per prescription fill.”

From the maker’s offer on jnjwithme.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Prezcobix Ped itself, from the same company, sold without the brand name, and usually for less. For now Prezcobix Ped is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

PREZCOBIX and PREZCOBIX PED are a two-drug combination of darunavir, a human immunodeficiency virus (HIV-1) protease inhibitor, and cobicistat, a CYP3A inhibitor, and are indicated for the treatment of HIV-1 in treatment-naïve and treatment-experienced adults and pediatric patients 3 years of age and older weighing at least 15 kg with no darunavir resistance-associated substitutions (V11I, V32I, L33F, I47V, I50V, I54L, I54M, T74P, L76V, I84V, L89V).

Source: the FDA label for Prezcobix Ped (Janssen Products, LP), February 1, 2026. Full label on DailyMed 

Good to know